» Articles » PMID: 33831567

Implications of SARS-Cov-2 Infection on ENOS and INOS Activity: Consequences for the Respiratory and Vascular Systems

Overview
Journal Nitric Oxide
Publisher Elsevier
Date 2021 Apr 8
PMID 33831567
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Symptoms of COVID-19 range from asymptomatic/mild symptoms to severe illness and death, consequence of an excessive inflammatory process triggered by SARS-CoV-2 infection. The diffuse inflammation leads to endothelium dysfunction in pulmonary blood vessels, uncoupling eNOS activity, lowering NO production, causing pulmonary physiological alterations and coagulopathy. On the other hand, iNOS activity is increased, which may be advantageous for host defense, once NO plays antiviral effects. However, overproduction of NO may be deleterious, generating a pro-inflammatory effect. In this review, we discussed the role of endogenous NO as a protective or deleterious agent of the respiratory and vascular systems, the most affected in COVID-19 patients, focusing on eNOS and iNOS roles. We also reviewed the currently available NO therapies and pointed out possible alternative treatments targeting NO metabolism, which could help mitigate health crises in the present and future CoV's spillovers.

Citing Articles

The effects of iron deficient and high iron diets on SARS-CoV-2 lung infection and disease.

Carolin A, Frazer D, Yan K, Bishop C, Tang B, Nguyen W Front Microbiol. 2024; 15:1441495.

PMID: 39296289 PMC: 11408339. DOI: 10.3389/fmicb.2024.1441495.


Cytokine-Induced iNOS in A549 Alveolar Epithelial Cells: A Potential Role in COVID-19 Lung Pathology.

Barilli A, Recchia Luciani G, Visigalli R, Sala R, Soli M, DallAsta V Biomedicines. 2023; 11(10).

PMID: 37893073 PMC: 10603955. DOI: 10.3390/biomedicines11102699.


Inhaled nitric oxide: can it serve as a savior for COVID-19 and related respiratory and cardiovascular diseases?.

Zhao Y, Li C, Zhang S, Cheng J, Liu Y, Han X Front Microbiol. 2023; 14:1277552.

PMID: 37849924 PMC: 10577426. DOI: 10.3389/fmicb.2023.1277552.


Mechanism of COVID-19-Induced Cardiac Damage from Patient, In Vitro and Animal Studies.

Jones E Curr Heart Fail Rep. 2023; 20(5):451-460.

PMID: 37526812 PMC: 10589152. DOI: 10.1007/s11897-023-00618-w.


Role of Olive Bioactive Compounds in Respiratory Diseases.

Vijakumaran U, Goh N, Razali R, Abdullah N, Yazid M, Sulaiman N Antioxidants (Basel). 2023; 12(6).

PMID: 37371870 PMC: 10295110. DOI: 10.3390/antiox12061140.


References
1.
Nicholson S, Lapa E Silva J, Nathan C, Xie Q, Mumford R, Weidner J . Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med. 1996; 183(5):2293-302. PMC: 2192561. DOI: 10.1084/jem.183.5.2293. View

2.
van den Berg M, Meurs H, Gosens R . Targeting arginase and nitric oxide metabolism in chronic airway diseases and their co-morbidities. Curr Opin Pharmacol. 2018; 40:126-133. DOI: 10.1016/j.coph.2018.04.010. View

3.
Akerstrom S, Mousavi-Jazi M, Klingstrom J, Leijon M, Lundkvist A, Mirazimi A . Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol. 2005; 79(3):1966-9. PMC: 544093. DOI: 10.1128/JVI.79.3.1966-1969.2005. View

4.
Kellner M, Noonepalle S, Lu Q, Srivastava A, Zemskov E, Black S . ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS). Adv Exp Med Biol. 2017; 967:105-137. PMC: 7120947. DOI: 10.1007/978-3-319-63245-2_8. View

5.
Greaves J, Chamberlain L . Palmitoylation-dependent protein sorting. J Cell Biol. 2007; 176(3):249-54. PMC: 2063950. DOI: 10.1083/jcb.200610151. View